Viemed Healthcare Inc (VMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Viemed Healthcare Inc stock (VMD) is currently trading at $9.35. Viemed Healthcare Inc PE ratio is 24.81. Viemed Healthcare Inc PS ratio (Price-to-Sales) is 1.31. Analyst consensus price target for VMD is $13.00. WallStSmart rates VMD as Hold.
- VMD PE ratio analysis and historical PE chart
- VMD PS ratio (Price-to-Sales) history and trend
- VMD intrinsic value — DCF, Graham Number, EPV models
- VMD stock price prediction 2025 2026 2027 2028 2029 2030
- VMD fair value vs current price
- VMD insider transactions and insider buying
- Is VMD undervalued or overvalued?
- Viemed Healthcare Inc financial analysis — revenue, earnings, cash flow
- VMD Piotroski F-Score and Altman Z-Score
- VMD analyst price target and Smart Rating
Viemed Healthcare Inc
📊 No data available
Try selecting a different time range
VMD Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Viemed Healthcare Inc (VMD)
VMD trades at a significant discount to its Graham intrinsic value of $17.32, offering a 51% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Viemed Healthcare Inc (VMD) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, revenue growth, eps growth. Fundamentals are solid but monitor weak areas for improvement.
Viemed Healthcare Inc (VMD) Key Strengths (4)
Paying $1.31 for every $1 of annual revenue
Strong revenue growth at 25.50% annually
Strong earnings growth at 29.80% per year
66.84% held by institutions, strong professional interest
Supporting Valuation Data
Viemed Healthcare Inc (VMD) Areas to Watch (5)
Thin operating margins with cost pressures present
Thin profit margins with limited profitability
Small-cap company with higher risk but more growth potential
Moderate profitability with room for improvement
Fairly priced relative to book value
Viemed Healthcare Inc (VMD) Detailed Analysis Report
Overall Assessment
This company scores 56/100 in our Smart Analysis, earning a C grade. Out of 9 metrics analyzed, 4 register as strengths (avg 8.0/10) while 5 fall into concern territory (avg 4.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Revenue Growth, EPS Growth. Valuation metrics including Price/Sales (1.31) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 25.50%, EPS Growth at 29.80%.
The Bear Case
The primary concerns are Operating Margin, Profit Margin, Market Cap. Some valuation metrics including Price/Book (2.51) suggest expensive pricing. Profitability pressure is visible in Return on Equity at 11.10%, Operating Margin at 11.50%, Profit Margin at 5.53%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 11.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 25.50% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Revenue Growth) and negatives (Operating Margin, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
VMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
VMD's Price-to-Sales ratio of 1.31x trades 44% below its historical average of 2.34x (13th percentile). The current valuation is 75% below its historical high of 5.18x set in Aug 2020, and 26% above its historical low of 1.04x in Jul 2025.
WallStSmart Analysis Synopsis
Data-driven financial summary for Viemed Healthcare Inc (VMD) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Viemed Healthcare Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 270M with 26% growth year-over-year. Profit margins are thin at 5.5%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Revenue growing at 26% YoY, reaching 270M. This pace significantly outperforms most MEDICAL DEVICES peers.
ROE of 1110.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
What to Watch Next
Margin expansion: can Viemed Healthcare Inc push profit margins above 15% as the business scales?
Growth sustainability: can Viemed Healthcare Inc maintain 26%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Viemed Healthcare Inc.
Bottom Line
Viemed Healthcare Inc offers an attractive blend of growth (26% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(137 last 3 months)
| Insider | Type | Shares |
|---|---|---|
MOORE, MICHAEL President | Sell | -65,000 |
| Insider | Type | Shares |
|---|---|---|
MOORE, MICHAEL President | Sell | -40,232 |
| Insider | Type | Shares |
|---|---|---|
MOORE, MICHAEL President | Sell | -31,570 |
Data sourced from SEC Form 4 filings
Last updated: 8:23:46 AM
About Viemed Healthcare Inc(VMD)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Viemed Healthcare, Inc. provides durable home medical equipment and post-acute respiratory health care services to patients in the United States. The company is headquartered in Lafayette, Louisiana.